Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mono versus dual antiplatelet therapy in acute cerebral infarction
ChiCTR1900024475Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Bengbu Medical University
- Start
- Aug 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of aspirin and clopidogrel in brain infarction and ischemic stroke (2 arms), sponsored by First Affiliated Hospital of Bengbu Medical University. Primary endpoints: mortality and muscle strength. Planned start Aug 2019; status: not yet recruiting.
02
Drugs
aspirinclopidogrel
03
Conditions
brain infarctionischemic stroke
Beyond the preview
Go deeper on ChiCTR1900024475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024475.